30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Menawat, Dr., Arun

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 48% 68% 82%
Transactions
8 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Menawat, Dr., Arun's trades of Profound Medical Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-20 2026-03-20
B Purchase
67,445 +39.3%
127.71
US$3,087,647 		67,445 +39.3% 127.71 US$3,087,647
2025-12-23 2025-12-23
B Purchase
85,626 -49.0%
47.90
US$419,131 		85,626 -49.0% 47.90 US$419,131
2025-05-16 2025-05-16
B Purchase
90,008 +46.4%
279.22
US$1,261,005 		90,008 +46.4% 279.22 US$1,261,005
2025-05-16 2025-05-15
B Purchase
10,003 +1.8%
4.33
US$43,263 		10,003 +1.8% 4.33 US$43,263
2025-03-18 2025-03-14
B Purchase
14,200 +2.6%
7.06
US$100,224 		14,200 +2.6% 7.06 US$100,224
2024-12-10 2024-12-10
B Purchase
20,000 +3.7%
7.50
US$150,000 		20,000 +3.7% 7.50 US$150,000
2023-12-22 2023-08-15
B Purchase
24,558 +5.6%
12.95
CA$318,026 		24,558 +5.6% 12.95 CA$318,026
2023-12-22 2023-05-21
B Purchase
12,589 +3.0%
17.41
CA$219,174 		12,589 +3.0% 17.41 CA$219,174
2022-12-20 2022-12-20
B Purchase
13,000 +3.0%
7.81
US$101,486 		13,000 +3.0% 7.81 US$101,486